Supplementary figure SF3 from Toxicity and Efficacy of Concurrent Androgen Deprivation Therapy, Pelvic Radiotherapy, and Radium-223 in Patients with &lt;i&gt;De Novo&lt;/i&gt; Metastatic Hormone-Sensitive Prostate Cancer